Trial Results Search
Clinical Trial Results: peginterferon alfa-2a [Pegasys]
-
Protocol Number: ML18089
Product Name: PEGASYS [peginterferon alfa-2a (40KD)]
Date of Report: 03.11.2008
Phase: III
-
Protocol Number: MV17117
Product Name: PEGASYS [peginterferon alfa-2a (40KD)]
Date of Report: 01.09.2008
Phase: III
-
Protocol Number: NO16006
Product Name: PEGASYS [peginterferon alfa-2a (40KD)]
Date of Report: 01.04.2008
Phase: III
-
Protocol Number: ML16814
Product Name: PEGASYS [peginterferon alfa-2a (40KD)]
Date of Report: 01.01.2009
Phase: IV
-
Protocol Number: BV16210
Product Name: PEGASYS [peginterferon alfa-2a (40KD)]
Date of Report: 01.06.2005
Phase: IV
-
Protocol Number: MV22430
Product Name: Pegasys [peginterferon alfa-2a]
Date of Report: To be Published
Phase: IV
-
Protocol Number: ML18286
Product Name: Pegasys [peginterferon alfa-2a [Pegasys]]
Date of Report: 01.02.2011
Phase: III
-
Protocol Number: NP17354
Product Name: PEGASYS [peginterferon alfa-2a (40KD)]
Date of Report: 01.05.2005
Phase: IV
-
Protocol Number: NP17355
Product Name: PEGASYS [peginterferon alfa-2a (40KD)]
Date of Report: 01.09.2008
Phase: IV
-
Protocol Number: ML16869
Product Name: PEGASYS [peginterferon alfa-2a (40KD)]
Date of Report: 01.10.2007
Phase: IV
-
Protocol Number: ML17908
Product Name: Pegasys [peginterferon alfa-2a [Pegasys]]
Date of Report: 01.11.2008
Phase: IV
-
Protocol Number: ML17619
Product Name: PEGASYS [peginterferon alfa-2a (40KD)]
Date of Report: 02.02.2007
Phase: III
-
Protocol Number: ML18232
Product Name: PEGASYS [peginterferon alfa-2a (40KD)]
Date of Report: 09.07.2009
Phase: II
-
Protocol Number: ML17756
Product Name: PEGASYS [peginterferon alfa-2a (40KD)]
Date of Report: 01.02.2007
Phase: IV
-
Protocol Number: ML18179
Product Name: PEGASYS [peginterferon alfa-2a (40KD)]
Date of Report: 22.04.2008
Phase: IV
-
Protocol Number: ML20090
Product Name: Pegasys [peginterferon alfa-2a [Pegasys]]
Date of Report: 10.06.2009
Phase: IV
-
Protocol Number: ML18124
Product Name: PEGASYS [peginterferon alfa-2a (40KD)]
Date of Report: 16.09.2009
Phase: IV
-
Protocol Number: NV18210
Product Name: peginterferon alfa-2a [Pegasys] [peginterferon alfa-2a]
Date of Report: 01.10.2009
Phase: IV
-
Protocol Number: NV18209
Product Name: peginterferon alfa-2a [Pegasys] [peginterferon alfa-2a]
Date of Report: 01.11.2009
Phase: IV
-
Protocol Number: ML18473
Product Name: PEGASYS [Peginterferon alfa-2a (40KD) [PEGASYS]]
Date of Report: 01.07.2010
Phase: IV
-
Protocol Number: ML18376
Product Name: Pegasys [peginterferon alfa-2a [Pegasys]]
Date of Report: 01.06.2010
Phase: IV
-
Protocol Number: ML16788
Product Name: Pegasys [peginterferon alfa-2a [Pegasys]]
Date of Report: 02.03.2009
Phase: IV
-
Protocol Number: ML21301
Product Name: peginterferon alfa-2a [Pegasys] [peginterferon alfa-2a]
Date of Report: 15.12.2011
Phase: IV
-
Protocol Number: MV17149
Product Name: Pegasys [peginterferon alfa-2a [Pegasys]]
Date of Report: 01.07.2008
Phase: IV
-
Protocol Number: MV17150
Product Name: PEGASYS [peginterferon alfa-2a (40KD)]
Date of Report: 03.12.2007
Phase: III
-
Protocol Number: ML18149
Product Name: Pegasys [peginterferon alfa-2a [Pegasys]]
Date of Report: 08.02.2013
Phase: II
-
Protocol Number: ML21779
Product Name: Pegasys [peginterferon alfa-2a]
Date of Report: To be Published
Phase: IV
-
Protocol Number: MV22597
Product Name: PEGINTERFERON ALFA-2A
Date of Report: To be Published
Phase: IV
-
Protocol Number: ML22265
Product Name: Pegasys [peginterferon alfa-2a]
Date of Report: To be Published
Phase: IV
-
Protocol Number: MV21371
Product Name: peginterferon alfa-2a
Date of Report: To be Published
Phase: III
-
Protocol Number: ML16837
Product Name: Pegasys [peginterferon alfa-2a]
Date of Report: To be Published
Phase: IV
-
Protocol Number: ML19387
Product Name: peginterferon alfa-2a
Date of Report: To be Published
Phase: IV
-
Protocol Number: ML21778
Product Name: Pegasys [peginterferon alfa-2a]
Date of Report: To be Published
Phase: IV
-
Protocol Number: ML22364
Product Name: peginterferon alfa-2a
Date of Report: To be Published
Phase: III
-
Protocol Number: ML21827
Product Name: Pegasys [peginterferon alfa-2a]
Date of Report: To be Published
Phase: IV
-
Protocol Number: ML18788
Product Name: Pegasys [peginterferon alfa-2a]
Date of Report: To be Published
Phase: III
A Study of PEGASYS (Peginterferon alfa-2a (40KD)) in Patients With Chronic Hepatitis D (CHD)
-
Protocol Number: WV19432
Product Name: peginterferon alfa-2a
Date of Report: To be Published
Phase: IV
-
Protocol Number: ML18253
Product Name: Pegasys [peginterferon alfa-2a]
Date of Report: To be Published
Phase: III
-
Protocol Number: ML20601
Product Name: peginterferon alfa-2a
Date of Report: To be Published
Phase: IV
-
Protocol Number: ML20135
Product Name: Pegasys [peginterferon alfa-2a]
Date of Report: To be Published
Phase: IV
-
Protocol Number: M78022
Product Name: Pegasys [peginterferon alfa-2a]
Date of Report: To be Published
Phase: III
-
Protocol Number: ML20742
Product Name: peginterferon alfa-2a
Date of Report: To be Published
Phase: IV
-
Protocol Number: ML17393
Product Name: Pegasys [peginterferon alfa-2a]
Date of Report: To be Published
Phase: IV
-
Protocol Number: NV21928
Product Name: peginterferon alfa-2a
Date of Report: To be Published
Phase: III
-
Protocol Number: ML28262
Product Name: Pegasys [peginterferon alfa-2a]
Date of Report: To be Published
Phase: II
-
Protocol Number: NV17590
Product Name: Pegasys [peginterferon alfa-2a]
Date of Report: To be Published
Phase: III
-
Protocol Number: ML17087
Product Name: Pegasys [peginterferon alfa-2a]
Date of Report: To be Published
Phase: IV
-
Protocol Number: YV25718
Product Name: Pegasys [peginterferon alfa-2a]
Date of Report: To be Published
Phase: III
-
Protocol Number: PP22612
Product Name: PEGASYS [peginterferon alfa-2a (40KB)]
Date of Report: To be Published
Phase: I
-
Protocol Number: ML22266
Product Name: Pegasys [peginterferon alfa-2a]
Date of Report: To be Published
Phase: IV
-
Protocol Number: ML16709
Product Name: PEGASYS [peginterferon alfa 2a (40KD)]
Date of Report: To be Published
Phase: IV
-
Protocol Number: ML19301
Product Name: Pegasys [peginterferon alfa-2a]
Date of Report: To be Published
Phase: II
-
Protocol Number: MV28073
Product Name: Pegasys [peginterferon alfa-2a]
Date of Report: To be Published
Phase: IV
-
Protocol Number: ML20622
Product Name: peginterferon alfa-2a
Date of Report: To be Published
Phase: III
-
Protocol Number: MV22009
Product Name: Pegasys [peginterferon alfa-2a]
Date of Report: To be Published
Phase: IV
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
-
Protocol Number: ML18495
Product Name: Pegasys [peginterferon alfa-2a [Pegasys]]
Date of Report: 31.10.2008
Phase: IV
-
Protocol Number: ML20434
Product Name: peginterferon alfa-2a [Pegasys] [peginterferon alfa-2a]
Date of Report: 27.03.2013
Phase: IV
-
Protocol Number: ML20003
Product Name: Pegasys [peginterferon alfa-2a [Pegasys]]
Date of Report: 01.12.2010
Phase: IV
-
Protocol Number: ML21543
Product Name: Pegasys [peginterferon alfa-2a [Pegasys]]
Date of Report: 18.11.2011
Phase: IV
-
Protocol Number: ML16965
Product Name: PEGASYS [peginterferon alfa-2a (40KD)]
Date of Report: 01.12.2006
Phase: IV
-
Protocol Number: ML18234
Product Name: peginterferon alfa-2a (40KD) [peginterferon alfa-2a]
Date of Report: 06.04.2010
Phase: III
-
Protocol Number: NO17754
Product Name: Pegasys [peginterferon alfa-2a [Pegasys]]
Date of Report: 01.08.2008
Phase: III
-
Protocol Number: ML17251
Product Name: PEGASYS [peginterferon alfa-2a (40KD)]
Date of Report: 01.06.2007
Phase: IV
-
Protocol Number: ML18092
Product Name: Pegasys [peginterferon alfa-2a [Pegasys]]
Date of Report: 17.12.2007
Phase: IV
-
Protocol Number: PP22512
Product Name: peginterferon alfa-2a [Pegasys] [peginterferon alfa-2a]
Date of Report: 01.09.2012
Phase: I
-
Protocol Number: ML18675
Product Name: Pegasys [peginterferon alfa-2a]
Date of Report: To be Published
Phase: III
-
Protocol Number: ML16536
Product Name: Pegasys [peginterferon alfa-2a]
Date of Report: To be Published
Phase: IV
-
Protocol Number: ML17700
Product Name: PEGASYS [peginterferon alfa-2a (40KD)]
Date of Report: 03.04.2006
Phase: IV
-
Protocol Number: ML17395
Product Name: Pegasys [peginterferon alfa-2a]
Date of Report: To be Published
Phase: III
-
Protocol Number: ML19295
Product Name: Pegasys [peginterferon alfa-2a [Pegasys]]
Date of Report: 30.07.2010
Phase: IV
-
Protocol Number: ML19522
Product Name: Pegasys [peginterferon alfa-2a [Pegasys]]
Date of Report: 01.12.2012
Phase: IV
-
Protocol Number: ML21035
Product Name: peginterferon alfa-2a
Date of Report: To be Published
Phase: III
-
Protocol Number: ML17131
Product Name: PEGASYS [peginterferon alfa-2a (40KD)]
Date of Report: 29.05.2007
Phase: IV
-
Protocol Number: BV16209
Product Name: PEGASYS [peginterferon alfa-2a (40KD)]
Date of Report: 03.03.2008
Phase: IV
-
Protocol Number: ML22936
Product Name: Pegasys [peginterferon alfa-2a [Pegasys]]
Date of Report: 14.03.2013
Phase: I
-
Protocol Number: NO16007
Product Name: PEGASYS [peginterferon alfa-2a (40KD)]
Date of Report: 01.10.2007
Phase: II
-
Protocol Number: MV21012
Product Name: Pegasys [peginterferon alfa-2a]
Date of Report: To be Published
Phase: IV
-
Protocol Number: MV21020
Product Name: Pegasys [peginterferon alfa-2a]
Date of Report: To be Published
Phase: IV
-
Protocol Number: MV21542
Product Name: Pegasys [peginterferon alfa-2a]
Date of Report: To be Published
Phase: IV
-
Protocol Number: NV17318
Product Name: PEGASYS [peginterferon alfa-2a (40KD)]
Date of Report: 01.10.2006
Phase: IV
-
Protocol Number: NV17317
Product Name: PEGASYS [peginterferon alfa-2a (40KD)]
Date of Report: 01.02.2006
Phase: IV
-
Protocol Number: ML20020
Product Name: Pegasys [peginterferon alfa-2a]
Date of Report: To be Published
Phase: II
-
Protocol Number: ML20399
Product Name: peginterferon alfa-2a
Date of Report: To be Published
Phase: IV
-
Protocol Number: NP25154
Product Name: Pegasys [peginterferon alfa 2a [Pegasys]]
Date of Report: 01.08.2010
Phase: I
About This Database
This database is populated with information on the results of Roche-sponsored clinical trials.